Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
8Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
MannKind Corporation (MNKD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
3Distinct source URLs
8High confidence
0.783Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
MannKind Corporation Suppliers
Ticker
Name
Confidence
Evidence
UNITED-THERAPEUTICS
UNITED-THERAPEUTICS
92%
In 23 August 2021, the Company and UT entered into the CSA pursuant to which the Company is responsible for manufacturing and supplying to UT, and UT is responsible for purchasing from the Company
FDKP-SUPPLIER
FDKP-SUPPLIER
90%
In the past, we purchased FDKP, the primary component of Technosphere powders, from a major chemical manufacturer with facilities in Europe and North America.
V-GO-CONTRACT-MANUFACTURER
V-GO-CONTRACT-MANUFACTURER
85%
V-Go is manufactured for us by a contract manufacturer ("CMO") in Southern China using MannKind-owned, custom-designed, semi-automated manufacturing equipment and production lines.
Reciprocal relationship from AMPH graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from AMPH graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from AMPH g…
Reciprocal relationship from BDRX graph: e downward pressure on health care costs in general, particularly prescription drugs, has become intense. As a result, increasingly high barriers are being er…
Reciprocal relationship from PULM graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from PULM graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from PULM g…
MannKind Corporation Customers
Ticker
Name
Confidence
Evidence
UNITED-THERAPEUTICS
UNITED-THERAPEUTICS
92%
Total revenue from UT was as follows (in thousands): Three Months Ended March 31, 2026 2025 Revenue from UT Royalties (1) $ 32,749 $ 30,005 UT CSA 22,015 28,818 UT License Agreement 1,000 — Total rev…
Reciprocal relationship from AMPH graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from AMPH graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from AMPH g…
. (3) Amounts represent royalties on UT’s net revenue from Tyvaso DPI sales. Year Ended December 31, 2024 2023 2022 Cost of goods sold and cost of revenue: Product revenue $ 73,737 $ 61,989 $ 55,071 …
Reciprocal relationship from BDRX graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from BDRX graph: ticles like Midatech GNPs are emerging as the fastest growing sector within …
Reciprocal relationship from PULM graph: primarily of costs incurred for the research and development of our preclinical and clinical candidates, and include: ● employee-related expenses, including s…
MANN-GROUP
MANN-GROUP
62%
revenue balance was $ 1.4 million, of which $ 0.2 million is classified as current and $ 1.2 million is classified as long term in the consolidated balance sheets. Amphastar — During the quarter ende…
N-A-MANN-GROUP
N-A-MANN-GROUP
62%
mary of Significant Accounting Policies . 89 Other Intangible Assets — Other intangible assets consisted of the following (in thousands): Estimated December 31, 2024 December 31, 2023 Useful Life (Ye…
ZEALAND-PHARMA-US-INC
ZEALAND-PHARMA-US-INC
62%
able, net $ 11,804 $ 14,901 ___________________________ (1) Includes the $ 1.1 million regulatory milestone payment receivable from Cipla. See Note 11 – Collaborations, Licensing and Other Arrangemen…
MannKind Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
MNKD-DEBT-11031
Warrants outstanding: 21562500
90%
xbrl warrant detail from xbrl 2020-12-31.
MNKD-DEBT
Debt stack $121.8M
90%
Market cache reports total debt of $121.8M.
MNKD-DEBT-11032
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
MannKind Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MannKind Corporation.
MannKind Corporation Ownership
Holder
Name
Confidence
Evidence
MNKD-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 255 tracked holders.
